Multiplex Screening for Pathogenic Hypertrophic Cardiomyopathy Mutations

This invention relates to a new method of screening for hypertrophic cardiomyopathy. In certain embodiments, the invention comprises a method of screening for hypertrophic cardiomyopathy comprising detecting the presence or absence of at least one pathogenic HCM mutation by mutation detection assay in a sample from a subject to be tested for hypertrophic cardiomyopathy.

Patents:
US 20,110,098,196

Inventor(s): DERMODY JAMES J [US]; SCHWALB MARVIN [US]; TOLIAS PETER [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent